Sucampo Pharmaceuticals, Inc. 4
4 · Sucampo Pharmaceuticals, Inc. · Filed Dec 19, 2007
Insider Transaction Report
Form 4
Tolliver Kei S
Director
Transactions
- Award
Employee Stock Option (Right to Buy)
2007-12-11+12,000→ 12,000 totalExercise: $14.12Exp: 2017-12-11→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]Vests as to 25% of the shares immediately, with the remaining shares vesting in equal installments over the next three annual anniversaries of the grant date.